| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/15/1992 | US5146730 Film-enrobed unitary-core medicament and the like |
| 09/15/1992 | CA2063011A1 Process for the microencapsulation of water-emulsifiable non-thermoplastic substances |
| 09/15/1992 | CA2062854A1 Pharmaceutical aerosol formulations |
| 09/15/1992 | CA1307465C Sucralfate preparations for application on esophagus mucosa |
| 09/15/1992 | CA1307464C Lyophilized or precipitated cephalosporin zwitterion and salt composition |
| 09/15/1992 | CA1307463C Sustained release pharmaceutical compositions |
| 09/12/1992 | CA2058059A1 Single layer transdermal drug administration system |
| 09/10/1992 | DE4107712A1 Topische seifengel-zubereitung Topical soap gel preparation |
| 09/10/1992 | DE4107153A1 Compsns. for application of active agents |
| 09/10/1992 | DE4107152A1 Compsns. for application of active agents |
| 09/09/1992 | WO1992015331A1 Lyophilized monoclonal antibody preparation |
| 09/09/1992 | WO1992015295A1 Compositions containing sumatriptan |
| 09/09/1992 | EP0502666A1 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
| 09/09/1992 | EP0502642A1 Sustained release compositions |
| 09/09/1992 | EP0502556A1 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of acid labile compounds |
| 09/09/1992 | EP0502502A1 Topical composition containing ketoprofen lysinate |
| 09/09/1992 | EP0502313A2 Method for insuring adequate intracellular glutathione in tissue |
| 09/09/1992 | EP0314764B1 Injectable opacifying liposome composition |
| 09/09/1992 | EP0227818B1 Antiglaucoma compositions |
| 09/09/1992 | CN1018151B Generic zero order controlled drug delivery system |
| 09/09/1992 | CA2082169A1 Freeze-dried preparation containing monoclonal antibody |
| 09/09/1992 | CA2062376A1 Medicinal composition |
| 09/08/1992 | US5145901 Seal, coatings, adhesiveness |
| 09/08/1992 | US5145871 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment |
| 09/08/1992 | US5145685 Skin treatment method and composition |
| 09/08/1992 | US5145684 Dispersion, bioavailability |
| 09/08/1992 | US5145683 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof |
| 09/08/1992 | US5145682 Estrogen |
| 09/08/1992 | US5145679 Topical emollient for prevention and treatment of circulatory induced lesions |
| 09/08/1992 | US5145675 Two step method for preparation of controlled release formulations |
| 09/08/1992 | US5145662 Ujv rad filters |
| 09/08/1992 | US5145604 Nonionic surfactant, polyol, ester |
| 09/08/1992 | US5145603 Ethylene oxide adducts, pumpable |
| 09/08/1992 | CA1307207C Steroid lotion |
| 09/08/1992 | CA1307205C Sustained release formulations |
| 09/05/1992 | CA2040761A1 Device for controlled release of a therapeutic agent |
| 09/03/1992 | WO1992014976A1 Method of microencapsulation of hyperbaric gas |
| 09/03/1992 | WO1992014731A1 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL |
| 09/03/1992 | WO1992014543A1 Unimolecular micelles and method of making the same |
| 09/03/1992 | WO1992014479A1 Composition for rectal administration of difficultly absorbable peptide |
| 09/03/1992 | WO1992014473A1 Steroid formulations |
| 09/03/1992 | WO1992014466A1 Pharmaceutical antitussive compositions |
| 09/03/1992 | WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 09/03/1992 | WO1992014451A1 Improvements in or relating to electrostatic coating of substrates of medicinal products |
| 09/03/1992 | WO1992014450A1 Sustained release drug delivery devices |
| 09/03/1992 | WO1992014449A1 Controlled release microparticulate delivery system for proteins |
| 09/03/1992 | WO1992014448A1 Binding of growth hormone to liposomes |
| 09/03/1992 | WO1992014447A1 Binding of recognizing substances to liposomes |
| 09/03/1992 | WO1992014446A1 Interaction between bioadhesive liposomes and target sites |
| 09/03/1992 | WO1992014445A1 Sustained drug release through topical application of bioadhesive liposomes |
| 09/03/1992 | WO1992014444A1 Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| 09/03/1992 | WO1992014443A1 Microsphere-in-oil emulsion |
| 09/03/1992 | WO1992014442A1 Composition for use in transdermal administration |
| 09/03/1992 | WO1992014404A1 Method and apparatus for injection of gas hydrates |
| 09/03/1992 | WO1992012715A3 The use of loperamide and related compounds for treatment of respiratory disease symptoms |
| 09/03/1992 | CA2079450A1 Interaction between bioadhesive liposomes and target sites |
| 09/02/1992 | WO1992015284A1 Gas and oxygen carrying lipid vesicles |
| 09/02/1992 | EP0501553A1 A method of highlighting intagliations in tablets |
| 09/02/1992 | EP0501552A1 4-[(2-Benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 09/02/1992 | EP0501523A1 Bioadhesive compositions |
| 09/02/1992 | EP0501056A1 Danazol containing compositions for the treatment of endometriosis |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500807A1 Tissue moisturizing composition and method |
| 09/02/1992 | EP0500802A1 Liposomal compositions. |
| 09/02/1992 | EP0500658A1 A nicotine containing stimulant unit. |
| 09/02/1992 | EP0500594A1 Small particle drug compositions |
| 09/02/1992 | EP0495918A4 Amino acid beta-lyase enzyme inhibitors as deodorants |
| 09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 09/02/1992 | EP0395656B1 Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives |
| 09/02/1992 | EP0335970B1 Tablet for use in the treatment of progesterone deficiency |
| 09/02/1992 | CN1064078A Steroid esters |
| 09/02/1992 | CN1064018A Processes for preparation of compositions used in treatment of cell generation disorders |
| 09/02/1992 | CA2106405A1 Gas and oxygen carrying lipid vesicles |
| 09/01/1992 | US5144016 Alginate gels |
| 09/01/1992 | US5143940 Isopropyl myristate as fatty component |
| 09/01/1992 | US5143934 Method and composition for controlled delivery of biologically active agents |
| 09/01/1992 | US5143917 Cationic tensides for controlling infections |
| 09/01/1992 | US5143731 Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| 09/01/1992 | US5143717 Burn foam and delivery system |
| 09/01/1992 | US5143661 A composition for microencapsulation of drugs for sustained release |
| 09/01/1992 | US5143126 Vibratory process and apparatus for agglomerating and metering non-flowable powders |
| 09/01/1992 | CA1306950C Buccal administration of estrogens |
| 09/01/1992 | CA1306949C Taste masking compositions |
| 09/01/1992 | CA1306948C Storage stable topical composition |
| 09/01/1992 | CA1306945C Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 08/29/1992 | WO1992015563A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/29/1992 | WO1992015282A2 Composition and method for delivery of drugs |
| 08/29/1992 | CA2104879A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/28/1992 | WO1992015289A1 Compositions and methods for topical administration of pharmaceutically active agents |
| 08/26/1992 | EP0500437A1 Ceramides, method for their preparation and their application in cosmetics and dermopharmacy |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | EP0499882A1 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataracts |
| 08/26/1992 | EP0499662A1 Compositions with enhanced penetration |
| 08/26/1992 | EP0499648A1 Enzymatically debranched starches as tablet excipients |
| 08/26/1992 | EP0480925A4 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 08/26/1992 | CN1063818A Improved antiperspirant formulations |
| 08/26/1992 | CN1017964B Skin external agent using as cosmetics matrix |
| 08/26/1992 | CA2104000A1 4-[(2-benzothiazolyl)methylamino] -.alpha.-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 08/25/1992 | US5141961 Mixing drug, polyethylene glycol, polyvinylpyrrolidone and solvent until dissolved, evaporating solvent |